Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs

J Antimicrob Chemother. 1996 Feb;37(2):351-6. doi: 10.1093/jac/37.2.351.

Abstract

The region of the gyrA gene encoding nucleotides 72 to 557 in ten Salmonella typhimurium clinical isolates received from Vellore, India and six British clinical isolates of a number of Salmonella species has been sequenced. Those exhibiting a decreased susceptibility to 4-quinolone drugs (MICs of ciprofloxacin ranging from 0.128 mg/L to 1.0 mg/L) have been shown to possess a number of different mutations in this region of the gene (Asp-87 to Gly, Asp-87 to Asn and Ser-83 to Phe). The mutations Asp-87 to Gly and Ser-83 to Phe/Asp-87 to Asn have yet to be reported occurring in S. typhimurium.

MeSH terms

  • Amino Acid Sequence
  • Anti-Infective Agents / pharmacology*
  • Base Sequence
  • Ciprofloxacin / pharmacology*
  • Drug Resistance, Microbial
  • Genes, Bacterial*
  • India
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Point Mutation*
  • Salmonella / drug effects*
  • Salmonella / genetics
  • Salmonella / isolation & purification
  • Salmonella typhimurium / drug effects*
  • Salmonella typhimurium / genetics
  • Salmonella typhimurium / isolation & purification
  • United Kingdom

Substances

  • Anti-Infective Agents
  • Ciprofloxacin